CN103784720A - Traditional Chinese medicinal preparation for reducing blood glucose and urine glucose - Google Patents
Traditional Chinese medicinal preparation for reducing blood glucose and urine glucose Download PDFInfo
- Publication number
- CN103784720A CN103784720A CN201310212696.XA CN201310212696A CN103784720A CN 103784720 A CN103784720 A CN 103784720A CN 201310212696 A CN201310212696 A CN 201310212696A CN 103784720 A CN103784720 A CN 103784720A
- Authority
- CN
- China
- Prior art keywords
- medicine
- accounts
- total
- ingredient composition
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 26
- 239000008280 blood Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract description 7
- 239000008103 glucose Substances 0.000 title abstract description 7
- 210000002700 urine Anatomy 0.000 title abstract description 5
- 239000003814 drug Substances 0.000 claims abstract description 226
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 15
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 15
- 235000008434 ginseng Nutrition 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims description 174
- 239000004615 ingredient Substances 0.000 claims description 171
- 239000000470 constituent Substances 0.000 claims description 40
- 239000009636 Huang Qi Substances 0.000 claims description 16
- 239000008517 radix Trichosanthis Substances 0.000 claims description 16
- 241000208340 Araliaceae Species 0.000 claims description 14
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 14
- 210000000582 semen Anatomy 0.000 claims description 14
- 230000001105 regulatory effect Effects 0.000 claims description 10
- 239000003053 toxin Substances 0.000 claims description 10
- 231100000765 toxin Toxicity 0.000 claims description 10
- 230000000694 effects Effects 0.000 abstract description 7
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 240000006688 Telosma cordata Species 0.000 abstract 1
- 235000017352 Telosma cordata Nutrition 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- 239000011505 plaster Substances 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010021118 Hypotonia Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 208000017561 flaccidity Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of plant materials in medical preparations in life need medicines, and in particular relates to a traditional Chinese medicinal preparation for reducing blood glucose and urine glucose. The preparation comprises astragalus membranaceus, prepared rehmannia root, Chinese violet, salviae miltiorrhizae, radices trichosanthis, rhizoma alismatis, cortex lycii radicis, schisandra chinensis, radix ophiopogonis, plantain seed, eucommia, rhizoma anemarrhenae, radix achyranthis bidentatae, spatholobus suberctu, ligusticum wallichii, plaster, ginseng, yam and rhizoma atractylodis. The traditional Chinese medicinal preparation is remarkable in curative effect, does not have adverse response, has an effective rate for improving hypoglycemic disorder of diabetes mellitus to be over 80 percent, is remarkable in effect for advanced symptom, and can well overcome defects in the prior art.
Description
Technical field
The invention belongs to the Material Field that derives from plant in living needs class medical science in medical configuration product, be specifically related to a kind of Chinese medicine preparation of blood sugar lowering glucose in urine.
Background technology
Prior art is generally to reduce patient's discomfort by the sugared content in dilute blood, actually cannot reach sanatory effect, and the present invention rebuilds body system and treats disease by improving the immune system of human body, customer service the deficiencies in the prior art.
The Chinese patent of the patent No.: CN201010291069.6, discloses a kind of Chinese medicine composition for the treatment of diabetes and preparation method thereof.The Chinese medicine composition for the treatment of diabetes of the present invention is made up of the raw material of following weight portion: Radix Astragali 12-30 part, Radix Puerariae 3-5 part, Rhizoma Dioscoreae 18-30 part, Rhizoma Anemarrhenae 9-15 part, Radix Trichosanthis 6-12 part, Fructus Schisandrae Chinensis 4-6 part, Endothelium Corneum Gigeriae Galli 3-5 part.The preparation method of Chinese medicine composition of the present invention is: the Radix Astragali, Radix Puerariae, Fructus Schisandrae Chinensis ethanol extraction, and extracting liquid filtering is collected filtrate, Rhizoma Dioscoreae, the Rhizoma Anemarrhenae, Radix Trichosanthis, with water extraction, extracting liquid filtering, filtrate is concentrated, precipitate with ethanol, filters, and collects filtrate; Merge gained filtrate, drying and crushing, mixes and get final product, but its curative effect is more single with Endothelium Corneum Gigeriae Galli fine powder, not obvious to patient's curative effect that symptom is heavier.
Summary of the invention
For addressing the above problem, the object of the invention is to provide a kind of Chinese medicine preparation of blood sugar lowering glucose in urine, and it is evident in efficacy and without negative interaction, to improving diabetes " blood sugar lowering " disease effective percentage more than 80 %, and to heavy successful, overcome preferably the deficiency that prior art exists.
The object of the present invention is achieved like this, and the constituent of a kind of QI and blood regulating eliminating toxin and beautifying the skin Chinese medicine preparation comprises the Radix Astragali, Radix Rehmanniae Preparata, Herba Violae, Radix Salviae Miltiorrhizae, Radix Trichosanthis, Rhizoma Alismatis, Cortex Lycii, Fructus Schisandrae Chinensis, Radix Ophiopogonis, Semen Plantaginis, the Cortex Eucommiae, the Rhizoma Anemarrhenae, Radix Achyranthis Bidentatae, Caulis Spatholobi, Rhizoma Chuanxiong, Gypsum Fibrosum, Radix Ginseng, Rhizoma Dioscoreae, Rhizoma Atractylodis, wherein the Radix Astragali accounts for 7～8% of the total constituent of medicine, wherein Radix Rehmanniae Preparata accounts for 7～8% of the total constituent of medicine, wherein Herba Violae accounts for 7～8% of the total constituent of medicine, wherein Radix Salviae Miltiorrhizae accounts for 3～4% of the total constituent of medicine, wherein Radix Trichosanthis accounts for 7～8% of the total constituent of medicine, wherein Rhizoma Alismatis accounts for 3～4% of the total constituent of medicine, wherein Cortex Lycii accounts for 3～4% of the total constituent of medicine, wherein Fructus Schisandrae Chinensis accounts for 2～3% of the total constituent of medicine, wherein account for 3～4% of the total constituent of medicine Radix Ophiopogonis, wherein Semen Plantaginis accounts for 3～4% of the total constituent of medicine, wherein the Cortex Eucommiae accounts for 3～4% of the total constituent of medicine, wherein the Rhizoma Anemarrhenae accounts for 3～4% of the total constituent of medicine, wherein Radix Achyranthis Bidentatae accounts for 3～4% of the total constituent of medicine, wherein Caulis Spatholobi accounts for 7～8% of the total constituent of medicine, wherein Rhizoma Chuanxiong accounts for 3～4% of the total constituent of medicine, wherein Gypsum Fibrosum accounts for 15～16% of the total constituent of medicine, wherein Radix Ginseng accounts for 3～4% of the total constituent of medicine, wherein Rhizoma Dioscoreae accounts for 3～4% of the total constituent of medicine, wherein Rhizoma Atractylodis account for 2～3% of the total constituent of medicine.
As further restriction of the present invention, the described Radix Astragali accounts for 7.6% of the total ingredient composition of medicine, Radix Rehmanniae Preparata accounts for 7.6% of the total ingredient composition of medicine, Herba Violae accounts for 7.6% of the total ingredient composition of medicine, Radix Salviae Miltiorrhizae accounts for 3.8% of the total ingredient composition of medicine, Radix Trichosanthis accounts for 7.6% of the total ingredient composition of medicine, Rhizoma Alismatis accounts for 3.8% of the total ingredient composition of medicine, Cortex Lycii accounts for 3.8% of the total ingredient composition of medicine, Fructus Schisandrae Chinensis accounts for 2.5% of the total ingredient composition of medicine, account for 3.8% of the total ingredient composition of medicine Radix Ophiopogonis, Semen Plantaginis accounts for 3.8% of the total ingredient composition of medicine, the Cortex Eucommiae accounts for 3.8% of the total ingredient composition of medicine, the Rhizoma Anemarrhenae accounts for 3.8% of the total ingredient composition of medicine, Radix Achyranthis Bidentatae accounts for 3.8% of the total ingredient composition of medicine, Caulis Spatholobi accounts for 7.6% of the total ingredient composition of medicine, Rhizoma Chuanxiong accounts for 3.8% of the total ingredient composition of medicine, Gypsum Fibrosum accounts for 15.2% of the total ingredient composition of medicine, Radix Ginseng accounts for 3.8% of the total ingredient composition of medicine, Rhizoma Dioscoreae accounts for 3.8% of the total ingredient composition of medicine, Rhizoma Atractylodis account for 2.5% of the total ingredient composition of medicine.
The Radix Astragali: sweet in the mouth, slightly warm in nature, returns liver, spleen, lung, kidney channel, QI invigorating good merchantable brand.
Radix Rehmanniae Preparata: turning bitter is the yang aspect of yin for sweet, vigour in energy the kidney invigorating.
Herba Violae: bitter, acrid, cold, nontoxic; GUIXIN, Liver Channel, heat-clearing and toxic substances removing, removing heat from blood detumescence.
Radix Salviae Miltiorrhizae: promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind.
Radix Trichosanthis: clearing away heat-fire, promoting the production of body fluid to quench thirst, evacuation of pus detumescence; Cure mainly: control calentura thirsty, quench one's thirst, jaundice, dryness of the lung hemoptysis, carbuncle, hemorrhoid flaccidity.
Rhizoma Alismatis: promoting diuresis to eliminate damp pathogen, expel the heat-evil, for dysuria, edema distension, the puckery pain of stranguria with turbid discharge, seminal emission, foot knee joint flaccidity is soft; Fry Rhizoma Alismatis, be partial to and spleen eliminating dampness by diuresis, for phlegm retention, dysentery, the vertigo.
Cortex Lycii: cold in nature, sweet in the mouth, removing heat from blood is except steaming, lung heat clearing pathogenic fire reducing; For deficiency of YIN hectic fever, hectic fever due to YIN-deficiency night sweat, cough due to lung-heat, spitting of blood, epistaxis.
Fructus Schisandrae Chinensis: astringe the lung, nourishing kidney, promotes the production of body fluid, receives antiperspirant, arresting seminal emission.
Radix Ophiopogonis: sweet, micro-hardship, is slightly cold; GUIXIN, lung, stomach warp, YIN nourishing and the production of body fluid promoting, lung moistening clears away heart-fire; For dryness of the lung dry cough, deficiency of YIN consumptive disease is coughed, sore throat pharyngalgia, and Tianjin wound is thirsty, and interior-heat is quenched one's thirst, vexed insomnia, dryness of the intestine constipation.
Semen Plantaginis: clearing away heat and promoting diuresis; Eliminating dampness by diuresis antidiarrheal; Improving eyesight; Eliminate the phlegm.Main dysuria; Stranguria with turbid discharge leukorrhagia; Edema distension; Heat-damp in summer dysentery; Conjunctival congestion is hidden from view; Expectorant heat syndrome cough is breathed heavily.
The Cortex Eucommiae: Gan Weixin, temperature, nontoxic, regulate the flow of vital energy and enrich blood.
The Rhizoma Anemarrhenae: clearing away heat-fire, promotes the production of body fluid and moisturizes; For fever caused by exogenous pathogenic factors, high hot excessive thirst, lung-heat type cough, osteopyrexia and fever, interior-heat is quenched one's thirst, dryness of the intestine constipation.
Radix Achyranthis Bidentatae: soreness of waist and knee joint; Flaccidity and weakness of the lower limbs; Amenorrhea due to stagnation of blood; Dysmenorrhea; Puerperal abdominal pain due to blood stasis; Lump in the abdomen; Retention of placenta; Pyretic stranguria; Stranguria with blood; Traumatic injury; Carbuncle malignant boil; Laryngopharynx swelling and pain.
Caulis Spatholobi: circulation of qi promoting, Fufeng, relaxing muscles and tendons to promote blood circulation effect.
Rhizoma Chuanxiong: rhizome of chuanxiong acrid in the mouth, warm in nature; Return liver, gallbladder, heart channel; There is blood-activating and qi-promoting, effect of wind-expelling pain-stopping.
Gypsum Fibrosum: sweet, Great Cold, nontoxic, clearing heat and relieving fidgetness.
Radix Ginseng: tonifying five ZANG-organs, peace spirit, determine soul, pathogen, the happy Fructus Alpiniae Oxyphyllae of improving eyesight, strongly invigorating primordial QI are throbbed with fear, removed to spasmolytic.
Rhizoma Dioscoreae: sweet in the mouth, property is flat; Return spleen, lung, kidney channel; Spleen reinforcing nourishing the stomach, the lung benefiting that promotes the production of body fluid, the kidney invigorating arresting seminal emission.
Rhizoma Atractylodis: pungent, bitter, temperature; Return spleen, stomach, Liver Channel; Distension and fullness in the abdomen, the edema of having loose bowels, beriberi flaccidity of feet with lamenness, rheumatic arthralgia.
The specific embodiment
embodiment 1
A kind of QI and blood regulating eliminating toxin and beautifying the skin Chinese medicine preparation, the described Radix Astragali accounts for 7.4% of the total ingredient composition of medicine, Radix Rehmanniae Preparata accounts for 7.6% of the total ingredient composition of medicine, Herba Violae accounts for 7.5% of the total ingredient composition of medicine, Radix Salviae Miltiorrhizae accounts for 3.8% of the total ingredient composition of medicine, Radix Trichosanthis accounts for 7.6% of the total ingredient composition of medicine, Rhizoma Alismatis accounts for 3.9% of the total ingredient composition of medicine, Cortex Lycii accounts for 3.5% of the total ingredient composition of medicine, Fructus Schisandrae Chinensis accounts for 2.7% of the total ingredient composition of medicine, account for 3.8% of the total ingredient composition of medicine Radix Ophiopogonis, Semen Plantaginis accounts for 3.8% of the total ingredient composition of medicine, the Cortex Eucommiae accounts for 3.8% of the total ingredient composition of medicine, the Rhizoma Anemarrhenae accounts for 3.8% of the total ingredient composition of medicine, Radix Achyranthis Bidentatae accounts for 3.8% of the total ingredient composition of medicine, Caulis Spatholobi accounts for 7.7% of the total ingredient composition of medicine, Rhizoma Chuanxiong accounts for 3.8% of the total ingredient composition of medicine, Gypsum Fibrosum accounts for 15.3% of the total ingredient composition of medicine, Radix Ginseng accounts for 3.8% of the total ingredient composition of medicine, Rhizoma Dioscoreae accounts for 3.9% of the total ingredient composition of medicine, Rhizoma Atractylodis account for 2.5% of the total ingredient composition of medicine.
embodiment 2
A kind of QI and blood regulating eliminating toxin and beautifying the skin Chinese medicine preparation, the described Radix Astragali accounts for 7.6% of the total ingredient composition of medicine, Radix Rehmanniae Preparata accounts for 7.8% of the total ingredient composition of medicine, Herba Violae accounts for 7.5% of the total ingredient composition of medicine, Radix Salviae Miltiorrhizae accounts for 3.6% of the total ingredient composition of medicine, Radix Trichosanthis accounts for 7.6% of the total ingredient composition of medicine, Rhizoma Alismatis accounts for 3.8% of the total ingredient composition of medicine, Cortex Lycii accounts for 3.9% of the total ingredient composition of medicine, Fructus Schisandrae Chinensis accounts for 2.5% of the total ingredient composition of medicine, account for 3.7% of the total ingredient composition of medicine Radix Ophiopogonis, Semen Plantaginis accounts for 3.6% of the total ingredient composition of medicine, the Cortex Eucommiae accounts for 3.7% of the total ingredient composition of medicine, the Rhizoma Anemarrhenae accounts for 3.8% of the total ingredient composition of medicine, Radix Achyranthis Bidentatae accounts for 3.8% of the total ingredient composition of medicine, Caulis Spatholobi accounts for 7.8% of the total ingredient composition of medicine, Rhizoma Chuanxiong accounts for 3.8% of the total ingredient composition of medicine, Gypsum Fibrosum accounts for 15.3% of the total ingredient composition of medicine, Radix Ginseng accounts for 3.8% of the total ingredient composition of medicine, Rhizoma Dioscoreae accounts for 3.8% of the total ingredient composition of medicine, Rhizoma Atractylodis account for 2.6% of the total ingredient composition of medicine.
embodiment 3
A kind of QI and blood regulating eliminating toxin and beautifying the skin Chinese medicine preparation, the described Radix Astragali accounts for 7.5% of the total ingredient composition of medicine, Radix Rehmanniae Preparata accounts for 7.5% of the total ingredient composition of medicine, Herba Violae accounts for 7.5% of the total ingredient composition of medicine, Radix Salviae Miltiorrhizae accounts for 3.8% of the total ingredient composition of medicine, Radix Trichosanthis accounts for 7.6% of the total ingredient composition of medicine, Rhizoma Alismatis accounts for 3.9% of the total ingredient composition of medicine, Cortex Lycii accounts for 3.8% of the total ingredient composition of medicine, Fructus Schisandrae Chinensis accounts for 2.7% of the total ingredient composition of medicine, account for 3.8% of the total ingredient composition of medicine Radix Ophiopogonis, Semen Plantaginis accounts for 3.8% of the total ingredient composition of medicine, the Cortex Eucommiae accounts for 3.6% of the total ingredient composition of medicine, the Rhizoma Anemarrhenae accounts for 3.8% of the total ingredient composition of medicine, Radix Achyranthis Bidentatae accounts for 3.7% of the total ingredient composition of medicine, Caulis Spatholobi accounts for 7.8% of the total ingredient composition of medicine, Rhizoma Chuanxiong accounts for 3.8% of the total ingredient composition of medicine, Gypsum Fibrosum accounts for 15.2% of the total ingredient composition of medicine, Radix Ginseng accounts for 3.8% of the total ingredient composition of medicine, Rhizoma Dioscoreae accounts for 3.9% of the total ingredient composition of medicine, Rhizoma Atractylodis account for 2.5% of the total ingredient composition of medicine.
embodiment 4
A kind of QI and blood regulating eliminating toxin and beautifying the skin Chinese medicine preparation, the described Radix Astragali accounts for 7.6% of the total ingredient composition of medicine, Radix Rehmanniae Preparata accounts for 7.6% of the total ingredient composition of medicine, Herba Violae accounts for 7.6% of the total ingredient composition of medicine, Radix Salviae Miltiorrhizae accounts for 3.9% of the total ingredient composition of medicine, Radix Trichosanthis accounts for 7.6% of the total ingredient composition of medicine, Rhizoma Alismatis accounts for 3.9% of the total ingredient composition of medicine, Cortex Lycii accounts for 3.9% of the total ingredient composition of medicine, Fructus Schisandrae Chinensis accounts for 2.3% of the total ingredient composition of medicine, account for 3.9% of the total ingredient composition of medicine Radix Ophiopogonis, Semen Plantaginis accounts for 3.9% of the total ingredient composition of medicine, the Cortex Eucommiae accounts for 3.9% of the total ingredient composition of medicine, the Rhizoma Anemarrhenae accounts for 3.9% of the total ingredient composition of medicine, Radix Achyranthis Bidentatae accounts for 3.9% of the total ingredient composition of medicine, Caulis Spatholobi accounts for 7.3% of the total ingredient composition of medicine, Rhizoma Chuanxiong accounts for 3.8% of the total ingredient composition of medicine, Gypsum Fibrosum accounts for 15.0% of the total ingredient composition of medicine, Radix Ginseng accounts for 3.8% of the total ingredient composition of medicine, Rhizoma Dioscoreae accounts for 3.9% of the total ingredient composition of medicine, Rhizoma Atractylodis account for 2.3% of the total ingredient composition of medicine.
embodiment 5
A kind of QI and blood regulating eliminating toxin and beautifying the skin Chinese medicine preparation, the described Radix Astragali accounts for 7.7% of the total ingredient composition of medicine, Radix Rehmanniae Preparata accounts for 7.6% of the total ingredient composition of medicine, Herba Violae accounts for 7.4% of the total ingredient composition of medicine, Radix Salviae Miltiorrhizae accounts for 3.6% of the total ingredient composition of medicine, Radix Trichosanthis accounts for 7.6% of the total ingredient composition of medicine, Rhizoma Alismatis accounts for 3.7% of the total ingredient composition of medicine, Cortex Lycii accounts for 3.8% of the total ingredient composition of medicine, Fructus Schisandrae Chinensis accounts for 2.7% of the total ingredient composition of medicine, account for 3.8% of the total ingredient composition of medicine Radix Ophiopogonis, Semen Plantaginis accounts for 3.6% of the total ingredient composition of medicine, the Cortex Eucommiae accounts for 3.9% of the total ingredient composition of medicine, the Rhizoma Anemarrhenae accounts for 3.8% of the total ingredient composition of medicine, Radix Achyranthis Bidentatae accounts for 3.7% of the total ingredient composition of medicine, Caulis Spatholobi accounts for 7.8% of the total ingredient composition of medicine, Rhizoma Chuanxiong accounts for 3.8% of the total ingredient composition of medicine, Gypsum Fibrosum accounts for 15.3% of the total ingredient composition of medicine, Radix Ginseng accounts for 3.8% of the total ingredient composition of medicine, Rhizoma Dioscoreae accounts for 3.8% of the total ingredient composition of medicine, Rhizoma Atractylodis account for 2.6% of the total ingredient composition of medicine.
embodiment 6
A kind of QI and blood regulating eliminating toxin and beautifying the skin Chinese medicine preparation, the described Radix Astragali accounts for 7.4% of the total ingredient composition of medicine, Radix Rehmanniae Preparata accounts for 7.8% of the total ingredient composition of medicine, Herba Violae accounts for 7.7% of the total ingredient composition of medicine, Radix Salviae Miltiorrhizae accounts for 3.8% of the total ingredient composition of medicine, Radix Trichosanthis accounts for 7.5% of the total ingredient composition of medicine, Rhizoma Alismatis accounts for 3.8% of the total ingredient composition of medicine, Cortex Lycii accounts for 3.8% of the total ingredient composition of medicine, Fructus Schisandrae Chinensis accounts for 2.4% of the total ingredient composition of medicine, account for 3.8% of the total ingredient composition of medicine Radix Ophiopogonis, Semen Plantaginis accounts for 3.6% of the total ingredient composition of medicine, the Cortex Eucommiae accounts for 3.9% of the total ingredient composition of medicine, the Rhizoma Anemarrhenae accounts for 3.9% of the total ingredient composition of medicine, Radix Achyranthis Bidentatae accounts for 3.7% of the total ingredient composition of medicine, Caulis Spatholobi accounts for 7.7% of the total ingredient composition of medicine, Rhizoma Chuanxiong accounts for 3.9% of the total ingredient composition of medicine, Gypsum Fibrosum accounts for 15.2% of the total ingredient composition of medicine, Radix Ginseng accounts for 3.7% of the total ingredient composition of medicine, Rhizoma Dioscoreae accounts for 3.7% of the total ingredient composition of medicine, Rhizoma Atractylodis account for 2.7% of the total ingredient composition of medicine.
embodiment 7
A kind of QI and blood regulating eliminating toxin and beautifying the skin Chinese medicine preparation, the described Radix Astragali accounts for 7.7% of the total ingredient composition of medicine, Radix Rehmanniae Preparata accounts for 7.5% of the total ingredient composition of medicine, Herba Violae accounts for 7.4% of the total ingredient composition of medicine, Radix Salviae Miltiorrhizae accounts for 3.7% of the total ingredient composition of medicine, Radix Trichosanthis accounts for 7.7% of the total ingredient composition of medicine, Rhizoma Alismatis accounts for 3.8% of the total ingredient composition of medicine, Cortex Lycii accounts for 3.8% of the total ingredient composition of medicine, Fructus Schisandrae Chinensis accounts for 2.5% of the total ingredient composition of medicine, account for 3.9% of the total ingredient composition of medicine Radix Ophiopogonis, Semen Plantaginis accounts for 3.6% of the total ingredient composition of medicine, the Cortex Eucommiae accounts for 3.9% of the total ingredient composition of medicine, the Rhizoma Anemarrhenae accounts for 3.7% of the total ingredient composition of medicine, Radix Achyranthis Bidentatae accounts for 3.6% of the total ingredient composition of medicine, Caulis Spatholobi accounts for 7.8% of the total ingredient composition of medicine, Rhizoma Chuanxiong accounts for 3.8% of the total ingredient composition of medicine, Gypsum Fibrosum accounts for 15.3% of the total ingredient composition of medicine, Radix Ginseng accounts for 3.9% of the total ingredient composition of medicine, Rhizoma Dioscoreae accounts for 3.7% of the total ingredient composition of medicine, Rhizoma Atractylodis account for 2.7% of the total ingredient composition of medicine.
Claims (2)
1. a QI and blood regulating eliminating toxin and beautifying the skin Chinese medicine preparation, constituent comprises the Radix Astragali, Radix Rehmanniae Preparata, Herba Violae, Radix Salviae Miltiorrhizae, Radix Trichosanthis, Rhizoma Alismatis, Cortex Lycii, Fructus Schisandrae Chinensis, Radix Ophiopogonis, Semen Plantaginis, the Cortex Eucommiae, the Rhizoma Anemarrhenae, Radix Achyranthis Bidentatae, Caulis Spatholobi, Rhizoma Chuanxiong, Gypsum Fibrosum, Radix Ginseng, Rhizoma Dioscoreae, Rhizoma Atractylodis, wherein the Radix Astragali accounts for 7～8% of the total constituent of medicine, wherein Radix Rehmanniae Preparata accounts for 7～8% of the total constituent of medicine, wherein Herba Violae accounts for 7～8% of the total constituent of medicine, wherein Radix Salviae Miltiorrhizae accounts for 3～4% of the total constituent of medicine, wherein Radix Trichosanthis accounts for 7～8% of the total constituent of medicine, wherein Rhizoma Alismatis accounts for 3～4% of the total constituent of medicine, wherein Cortex Lycii accounts for 3～4% of the total constituent of medicine, wherein Fructus Schisandrae Chinensis accounts for 2～3% of the total constituent of medicine, wherein account for 3～4% of the total constituent of medicine Radix Ophiopogonis, wherein Semen Plantaginis accounts for 3～4% of the total constituent of medicine, wherein the Cortex Eucommiae accounts for 3～4% of the total constituent of medicine, wherein the Rhizoma Anemarrhenae accounts for 3～4% of the total constituent of medicine, wherein Radix Achyranthis Bidentatae accounts for 3～4% of the total constituent of medicine, wherein Caulis Spatholobi accounts for 7～8% of the total constituent of medicine, wherein Rhizoma Chuanxiong accounts for 3～4% of the total constituent of medicine, wherein Gypsum Fibrosum accounts for 15～16% of the total constituent of medicine, wherein Radix Ginseng accounts for 3～4% of the total constituent of medicine, wherein Rhizoma Dioscoreae accounts for 3～4% of the total constituent of medicine, wherein Rhizoma Atractylodis account for 2～3% of the total constituent of medicine.
2. a kind of QI and blood regulating eliminating toxin and beautifying the skin Chinese medicine preparation according to claim 1, it is characterized in that: the described Radix Astragali accounts for 7.6% of the total ingredient composition of medicine, Radix Rehmanniae Preparata accounts for 7.6% of the total ingredient composition of medicine, Herba Violae accounts for 7.6% of the total ingredient composition of medicine, Radix Salviae Miltiorrhizae accounts for 3.8% of the total ingredient composition of medicine, Radix Trichosanthis accounts for 7.6% of the total ingredient composition of medicine, Rhizoma Alismatis accounts for 3.8% of the total ingredient composition of medicine, Cortex Lycii accounts for 3.8% of the total ingredient composition of medicine, Fructus Schisandrae Chinensis accounts for 2.5% of the total ingredient composition of medicine, account for 3.8% of the total ingredient composition of medicine Radix Ophiopogonis, Semen Plantaginis accounts for 3.8% of the total ingredient composition of medicine, the Cortex Eucommiae accounts for 3.8% of the total ingredient composition of medicine, the Rhizoma Anemarrhenae accounts for 3.8% of the total ingredient composition of medicine, Radix Achyranthis Bidentatae accounts for 3.8% of the total ingredient composition of medicine, Caulis Spatholobi accounts for 7.6% of the total ingredient composition of medicine, Rhizoma Chuanxiong accounts for 3.8% of the total ingredient composition of medicine, Gypsum Fibrosum accounts for 15.2% of the total ingredient composition of medicine, Radix Ginseng accounts for 3.8% of the total ingredient composition of medicine, Rhizoma Dioscoreae accounts for 3.8% of the total ingredient composition of medicine, Rhizoma Atractylodis account for 2.5% of the total ingredient composition of medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310212696.XA CN103784720A (en) | 2013-06-01 | 2013-06-01 | Traditional Chinese medicinal preparation for reducing blood glucose and urine glucose |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310212696.XA CN103784720A (en) | 2013-06-01 | 2013-06-01 | Traditional Chinese medicinal preparation for reducing blood glucose and urine glucose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103784720A true CN103784720A (en) | 2014-05-14 |
Family
ID=50661057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310212696.XA Pending CN103784720A (en) | 2013-06-01 | 2013-06-01 | Traditional Chinese medicinal preparation for reducing blood glucose and urine glucose |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103784720A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106109893A (en) * | 2016-06-21 | 2016-11-16 | 云南恒健辣木发展有限公司 | A kind of food and medicament dual-purpose Chinese medicine composition superfine powder and preparation method thereof |
| WO2022036195A1 (en) * | 2020-08-14 | 2022-02-17 | Gubler Daniel A | Phytonutrient compositions able to lower postprandial blood-glucose levels through regulation of signal transduction cascades |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006290875A (en) * | 2005-03-15 | 2006-10-26 | Toyo Shinyaku:Kk | Improving agent for energy utilization efficiency |
| CN101716294A (en) * | 2009-12-24 | 2010-06-02 | 天津中天制药有限公司 | Drop pill for treating diabetes mellitus |
-
2013
- 2013-06-01 CN CN201310212696.XA patent/CN103784720A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006290875A (en) * | 2005-03-15 | 2006-10-26 | Toyo Shinyaku:Kk | Improving agent for energy utilization efficiency |
| CN101716294A (en) * | 2009-12-24 | 2010-06-02 | 天津中天制药有限公司 | Drop pill for treating diabetes mellitus |
Non-Patent Citations (2)
| Title |
|---|
| UFOBYSDJN: "01权健自然医学养生调理诊疗", 《HTTPS://WENKU.BAIDU.COM/VIEW/75E5A62B482FB4DAA58D4BC2.HTML》 * |
| 周丹等: "益气健脾法治疗2型糖尿病的临床观察", 《湖北中医杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106109893A (en) * | 2016-06-21 | 2016-11-16 | 云南恒健辣木发展有限公司 | A kind of food and medicament dual-purpose Chinese medicine composition superfine powder and preparation method thereof |
| WO2022036195A1 (en) * | 2020-08-14 | 2022-02-17 | Gubler Daniel A | Phytonutrient compositions able to lower postprandial blood-glucose levels through regulation of signal transduction cascades |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102727859B (en) | Traditional Chinese medicine hair blackening composition, extracting solution thereof and traditional Chinese medicine hair blackening solution | |
| CN102430079B (en) | Traditional Chinese medicine composite for treating stranguria | |
| CN103908640A (en) | Traditional Chinese medicinal composition for treating liver cirrhosis | |
| CN103536758A (en) | Traditional Chinese medicinal composition for treating night sweat due to yin deficiency | |
| CN104352776A (en) | Traditional Chinese medicine preparation for treating infertility caused by hypomenorrhea and preparation method thereof | |
| CN103463586B (en) | A kind of Chinese medicine composition for the treatment of restless legs syndrome | |
| CN105816833A (en) | Traditional Chinese medicinal formula for treating dysmenorrhea and preparation method thereof | |
| CN103110762A (en) | Traditional Chinese medicine composition for treating old fracture | |
| CN104225166A (en) | Chinese medicine composition for treating amenorrhea and preparation method thereof | |
| CN102631655B (en) | Medicine for treating coronary heart disease and preparation method for medicine | |
| CN103520668B (en) | Traditional Chinese medicine for treating heart and qi deficiency symptom type chest stuffiness and pains | |
| CN103223024B (en) | Diabetes mellitus dialectical traditional Chinese medicine prescription | |
| CN103784720A (en) | Traditional Chinese medicinal preparation for reducing blood glucose and urine glucose | |
| CN101129683A (en) | Orally taken traditional Chinese medicine composition for treating chloasma | |
| CN103800697A (en) | Traditional Chinese medicine composition for treating pharyngitis | |
| CN105056170A (en) | Application of traditional Chinese medicine composition in preparing drug for treating acute gastritis | |
| CN104606600A (en) | Traditional Chinese medicine composition for treating interstitial lung disease and preparation method of composition | |
| CN103656199B (en) | A kind of Chinese medicine for the treatment of deficiency of kidney yin syndrome cough | |
| CN102988890A (en) | Pure Chinese medicine preparation for treating chloasma | |
| CN106421599A (en) | Traditional Chinese medicine for treating diabetes mellitus and preparation method of traditional Chinese medicine | |
| CN105999019A (en) | Traditional Chinese medicine preparation for enhancing chemotherapeutic effect on breast cancer and preparation method of traditional Chinese medicine preparation | |
| CN105250618A (en) | Antiviral traditional Chinese medicine composition for treating liver cirrhosis and preparation method thereof | |
| CN105148164A (en) | Antai Buqi Chinese herbal medicament for livestock | |
| CN105521384A (en) | Gynecological medicine for treating pregnancy complications, and preparation method thereof | |
| CN104288365A (en) | Traditional Chinese medicine for treating amenorrhea due to qi stagnation and blood stasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160909 Address after: 655500 Qujing Fuyuan County, Yunnan Province town of Longhai Village Committee on the old house on the agency No. 37 Applicant after: Cao Yuqiong Address before: Longma village Guandu town Guandu District Yunnan city Kunming province 650000 No. 114 of No. 2 Applicant before: Lv Han |
|
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140514 |